Skip to main content
. 2020 Nov 8;35(2):464–475. doi: 10.1111/jdv.16928

Figure 3.

Figure 3

Efficacy outcomes in the two age cohorts (≥6 months to <2 years and ≥2 to <6 years): (a) mean percentage change from baseline to week 4 in EASI; (b) mean percentage change from baseline to week 4 in SCORAD score; (c) proportions of patients with EASI‐50; (d) proportions of patients with EASI‐75 from baseline to week 4; (e) mean percentage change from baseline to week 4 in caregiver‐reported Peak Pruritus NRS. EASI, Eczema Area and Severity Index; EASI‐50/‐75, ≥50%/≥75% improvement from baseline in EASI; NRS, numerical rating scale; SCORAD, SCORing Atopic Dermatitis; SD, standard deviation.